A Prospective, Randomized, Controlled, Multi-Center Study to Establish the Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients who have Severe, Calcific Aortic Stenosis Requiring Aortic Valve Replacement

September 17, 2018
https://clinicaltrials.gov/ct2/results?id=NCT02675114
Cardiac, Cardiac and Thoracic Surgery, Heart
Principal Investigator: William W O Neill, MD
aortic valve stenosis, TAVR, low risk, transcatheter aortic valve replacement, Partner 3, william o'neill
Accepting Participants